Navigation Links
Sinovac Participates in Two Investor Conferences in November
Date:10/27/2010

BEIJING, Oct. 27 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today that Mr. Jacob Ho, Acting Chief Financial Officer, Ms. Vanessa Wu, Senior Financial Manager and Ms. Helen Yang, Investor Relations Manager, are scheduled to present at two upcoming investor conferences to be held in early November.

  • Goldman Sachs China Investment Frontier Conference 2010, Beijing, China, November 1-2: Sinovac is participating in one-on-one and group meetings on November 1
  • Bank of America Merrill Lynch China Investment Summit, Beijing China, November 1-5: Sinovac is participating in one-on-one meetings on November 3

  • About SinovacSinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases including hepatitis A, seasonal influenza, H5N1 (bird flu) pandemic influenza and H1N1 influenza. In 2009, Sinovac was the first company worldwide to receive approval for its H1N1 influenza vaccine, PANFLU.1, and has received the orders from the Chinese Central Government pursuit to the government stockpiling program. The Company is developing a number of new vaccine products, including vaccines for pneumococcal conjugate, enterovirus 71 (EV71) (against Hand, Foot & Mouth Disease), Japanese Encephalitis, animal and human rabies, HIB and epidemic meningitis, chickenpox, mumps and rubella. Its wholly owned subsidiary, Tangshan Yian, is focusing on the research, development, manufacturing and commercialization of animal vaccines and has completed the field trials for an independently developed inactivated animal rabies vaccine, which is anticipated to be launched into market in 2011.

    Safe Harbor StatementThis announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Sinovac does not undertake any obligation to update any forward-looking statement, except as required under applicable law.Helen YangSinovac Biotech Ltd.Tel:  +86-10-8279-9871Fax:  +86-10-6296-6910Email: info@sinovac.com Investors:Stephanie Carrington/Amy GlynnThe Ruth GroupTel:  +1-646-536-7017/7023Email: scarrington@theruthgroup.comaglynn@theruthgroup.comMediaJason RandoThe Ruth GroupTel:  +1-646-536-7025Email:  jrando@theruthgroup.com
    '/>"/>

    SOURCE Sinovac Biotech Ltd.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
    2. Sinovac Reports Record Second Quarter 2008 Unaudited Financial Results
    3. Sinovac to Present at the Susquehanna Financial Groups Second Annual Beijing Management Summit Conference
    4. Sinovac Adjourns Annual General Meeting
    5. Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season
    6. Sinovac Initiates Clinical Trials for Inactivated Hepatitis A Vaccine in Ukraine
    7. Sinovac to Present at the 2008 UBS Global Life Sciences Conference
    8. Sinovac Biotech Holds 2007 Annual General Meeting
    9. Sinovacs Credit Rating Upgraded to AAZ, Second Highest Rating
    10. Sinovac to Participate in Two Upcoming Investor Conferences
    11. Sinovac Named to Deloitte Technology Fast 50 China
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/5/2016)... , December 5, 2016 ... worldwide, with almost $108 billion of revenue and some ... billion were spent on global biopharmaceuticals, and this figure ... morning, Stock-Callers.com has lined up these four equities for ... ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda ...
    (Date:12/4/2016)... SPRINGFIELD, Mass. and CAMBRIDGE, ... South Africa , Dec. 4, 2016 /PRNewswire/ ... and providing connected diagnostics software platforms for the ... on making "Anywhere. Care.™" a reality with its ... companies have entered into a development and license ...
    (Date:12/2/2016)... Amgen (NASDAQ: AMGN ) and Allergan ... of a Marketing Authorization Application (MAA) to the European Medicines ... ® (bevacizumab). The companies believe this submission is the ... "The submission of ABP 215 to the EMA is ... portfolio," said Sean E. Harper , M.D., executive vice ...
    (Date:12/2/2016)... San Antonio Texas (PRWEB) , ... ... ... announced today that it will share findings demonstrating the value of DNA ... cancer patients at this year’s San Antonio Breast Cancer Symposium. Using molecular ...
    Breaking Biology Technology:
    (Date:11/14/2016)... Nov. 14, 2016  xG Technology, Inc. ("xG" or ... critical wireless communications for use in challenging operating environments, ... 30, 2016. Management will hold a conference call to ... p.m. Eastern Time (details below). Key Recent ... $16 million binding agreement to acquire Vislink Communication Systems. ...
    (Date:6/27/2016)... DUBLIN , June 27, 2016 Research ... in North America 2016-2020" report to their offering. ... North America to grow at a CAGR ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
    (Date:6/22/2016)... June 22, 2016   Acuant , ... verification solutions, has partnered with RightCrowd ® ... for Visitor Management, Self-Service Kiosks and Continuous ... that add functional enhancements to existing physical ... and venues with an automated ID verification ...
    Breaking Biology News(10 mins):